Why the study?
Does siRNA-mediated knockdown of SMG-1 or Upf1 rescue the phenotype of Ullrich disease fibroblasts?
Does siRNA-mediated knockdown of SMG-1 or Upf1 rescue the phenotype of Ullrich disease fibroblasts?
Inhibition of nonsense-mediated mRNA decay via SMG-1 or Upf1 knockdown rescues the cellular phenotype in Ullrich disease fibroblasts, suggesting a potential therapeutic approach for genetic diseases exacerbated by NMD.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for NMD inhibition in Ullrich disease; leaves open in vivo efficacy and clinical translation.
Usuki et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: